vs
Side-by-side financial comparison of Sensus Healthcare, Inc. (SRTS) and Velo3D, Inc. (VELO). Click either name above to swap in a different company.
Velo3D, Inc. is the larger business by last-quarter revenue ($9.4M vs $4.9M, roughly 1.9× Sensus Healthcare, Inc.). Sensus Healthcare, Inc. runs the higher net margin — -64.1% vs -231.9%, a 167.8% gap on every dollar of revenue. On growth, Velo3D, Inc. posted the faster year-over-year revenue change (-25.2% vs -62.2%). Sensus Healthcare, Inc. produced more free cash flow last quarter ($-2.4M vs $-8.3M). Over the past eight quarters, Velo3D, Inc.'s revenue compounded faster (-1.8% CAGR vs -31.9%).
Sensus Healthcare, Inc. is a medical technology company that designs, manufactures and commercializes innovative non-invasive superficial radiation therapy systems. Its products are primarily used for treating non-melanoma skin cancers, keloids, and select cosmetic dermatology conditions, serving healthcare providers and clinical facilities worldwide.
Velo3D, Inc. develops and sells advanced end-to-end metal additive manufacturing (3D printing) solutions, comprising industrial-grade printers, specialized processing software, and high-performance metal materials. It primarily serves global aerospace, defense, energy, semiconductor and industrial manufacturing markets, enabling customers to produce complex, high-precision metal parts that are difficult to manufacture with traditional methods.
SRTS vs VELO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $4.9M | $9.4M |
| Net Profit | $-3.2M | $-21.9M |
| Gross Margin | 38.4% | -73.6% |
| Operating Margin | -63.8% | -231.0% |
| Net Margin | -64.1% | -231.9% |
| Revenue YoY | -62.2% | -25.2% |
| Net Profit YoY | -304.9% | -2.9% |
| EPS (diluted) | $-0.19 | $-0.87 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $4.9M | $9.4M | ||
| Q3 25 | $6.9M | $13.6M | ||
| Q2 25 | $7.3M | $13.6M | ||
| Q1 25 | $8.3M | $9.3M | ||
| Q4 24 | $13.1M | $12.6M | ||
| Q3 24 | $8.8M | $8.2M | ||
| Q2 24 | $9.2M | $10.3M | ||
| Q1 24 | $10.7M | $9.8M |
| Q4 25 | $-3.2M | $-21.9M | ||
| Q3 25 | $-943.0K | $-11.2M | ||
| Q2 25 | $-1.0M | $-13.3M | ||
| Q1 25 | $-2.6M | $-25.0M | ||
| Q4 24 | $1.5M | $-21.3M | ||
| Q3 24 | $1.2M | $-21.9M | ||
| Q2 24 | $1.6M | $935.0K | ||
| Q1 24 | $2.3M | $-27.5M |
| Q4 25 | 38.4% | -73.6% | ||
| Q3 25 | 39.4% | 3.2% | ||
| Q2 25 | 39.7% | -11.7% | ||
| Q1 25 | 52.2% | 7.5% | ||
| Q4 24 | 54.4% | -3.5% | ||
| Q3 24 | 59.3% | 49.4% | ||
| Q2 24 | 58.7% | -28.0% | ||
| Q1 24 | 62.5% | -28.8% |
| Q4 25 | -63.8% | -231.0% | ||
| Q3 25 | -37.3% | -73.3% | ||
| Q2 25 | -26.6% | -85.4% | ||
| Q1 25 | -31.7% | -123.6% | ||
| Q4 24 | 13.2% | -167.0% | ||
| Q3 24 | 16.9% | -213.8% | ||
| Q2 24 | 21.5% | -187.7% | ||
| Q1 24 | 27.1% | -211.1% |
| Q4 25 | -64.1% | -231.9% | ||
| Q3 25 | -13.7% | -82.0% | ||
| Q2 25 | -14.2% | -97.7% | ||
| Q1 25 | -30.8% | -268.4% | ||
| Q4 24 | 11.8% | -168.5% | ||
| Q3 24 | 13.7% | -265.3% | ||
| Q2 24 | 17.4% | 9.0% | ||
| Q1 24 | 21.3% | -281.2% |
| Q4 25 | $-0.19 | $-0.87 | ||
| Q3 25 | $-0.06 | $-0.65 | ||
| Q2 25 | $-0.06 | $-0.94 | ||
| Q1 25 | $-0.16 | $-1.87 | ||
| Q4 24 | $0.10 | $7.06 | ||
| Q3 24 | $0.07 | $-35.52 | ||
| Q2 24 | $0.10 | $1.65 | ||
| Q1 24 | $0.14 | $-55.51 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $22.1M | $39.0M |
| Total DebtLower is stronger | — | $31.0M |
| Stockholders' EquityBook value | $48.1M | $38.2M |
| Total Assets | $53.0M | $105.3M |
| Debt / EquityLower = less leverage | — | 0.81× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $22.1M | $39.0M | ||
| Q3 25 | $24.5M | $11.8M | ||
| Q2 25 | $22.2M | $854.0K | ||
| Q1 25 | $19.1M | $3.9M | ||
| Q4 24 | $22.1M | $1.2M | ||
| Q3 24 | $22.6M | $1.6M | ||
| Q2 24 | $19.0M | $3.2M | ||
| Q1 24 | $14.7M | $10.9M |
| Q4 25 | — | $31.0M | ||
| Q3 25 | — | $23.0M | ||
| Q2 25 | — | $22.5M | ||
| Q1 25 | — | $21.7M | ||
| Q4 24 | — | $5.7M | ||
| Q3 24 | — | $32.3M | ||
| Q2 24 | — | $33.5M | ||
| Q1 24 | — | $44.0M |
| Q4 25 | $48.1M | $38.2M | ||
| Q3 25 | $51.2M | $29.9M | ||
| Q2 25 | $52.1M | $21.4M | ||
| Q1 25 | $53.0M | $32.8M | ||
| Q4 24 | $55.8M | $39.7M | ||
| Q3 24 | $54.1M | $34.4M | ||
| Q2 24 | $52.9M | $52.1M | ||
| Q1 24 | $51.2M | $45.5M |
| Q4 25 | $53.0M | $105.3M | ||
| Q3 25 | $58.3M | $93.7M | ||
| Q2 25 | $58.9M | $78.4M | ||
| Q1 25 | $60.2M | $91.3M | ||
| Q4 24 | $62.2M | $89.2M | ||
| Q3 24 | $59.9M | $110.8M | ||
| Q2 24 | $58.2M | $116.7M | ||
| Q1 24 | $57.3M | $136.1M |
| Q4 25 | — | 0.81× | ||
| Q3 25 | — | 0.77× | ||
| Q2 25 | — | 1.05× | ||
| Q1 25 | — | 0.66× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | — | 0.94× | ||
| Q2 24 | — | 0.64× | ||
| Q1 24 | — | 0.97× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.2M | $-7.7M |
| Free Cash FlowOCF − Capex | $-2.4M | $-8.3M |
| FCF MarginFCF / Revenue | -47.9% | -88.3% |
| Capex IntensityCapex / Revenue | 3.2% | 6.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $332.0K | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.2M | $-7.7M | ||
| Q3 25 | $2.3M | $-6.0M | ||
| Q2 25 | $3.1M | $-1.2M | ||
| Q1 25 | $-2.7M | $-12.3M | ||
| Q4 24 | $-827.0K | $-2.2M | ||
| Q3 24 | $4.0M | $-2.0M | ||
| Q2 24 | $4.2M | $-8.0M | ||
| Q1 24 | $-8.2M | $-20.5M |
| Q4 25 | $-2.4M | $-8.3M | ||
| Q3 25 | $2.3M | $-6.3M | ||
| Q2 25 | $3.1M | $-3.0M | ||
| Q1 25 | $-2.7M | — | ||
| Q4 24 | $-1.1M | $-2.2M | ||
| Q3 24 | $3.6M | $-2.0M | ||
| Q2 24 | $4.2M | $-8.0M | ||
| Q1 24 | $-8.4M | $-20.5M |
| Q4 25 | -47.9% | -88.3% | ||
| Q3 25 | 33.3% | -46.5% | ||
| Q2 25 | 42.2% | -22.2% | ||
| Q1 25 | -32.2% | — | ||
| Q4 24 | -8.6% | -17.7% | ||
| Q3 24 | 40.9% | -24.2% | ||
| Q2 24 | 45.8% | -77.1% | ||
| Q1 24 | -79.0% | -209.8% |
| Q4 25 | 3.2% | 6.4% | ||
| Q3 25 | 0.1% | 2.3% | ||
| Q2 25 | 0.4% | 13.3% | ||
| Q1 25 | 0.1% | 0.0% | ||
| Q4 24 | 2.3% | 0.2% | ||
| Q3 24 | 3.8% | 0.2% | ||
| Q2 24 | 0.0% | 0.0% | ||
| Q1 24 | 2.2% | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -0.53× | — | ||
| Q3 24 | 3.25× | — | ||
| Q2 24 | 2.62× | -8.52× | ||
| Q1 24 | -3.60× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SRTS
| Products | $2.8M | 57% |
| Other | $2.1M | 43% |
VELO
Segment breakdown not available.
